Abstract
BackgroundTumor programmed death-receptor/ligand-1 (PD-1/PD-L1) expression negatively correlates with cancer prognosis and overall survival, 1-6 and has been shown to predict clinical responses to immunotherapy for head and neck cancers.7 In...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
